A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously Treated Non–Small-Cell Lung Cancer
Titel:
A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously Treated Non–Small-Cell Lung Cancer
Auteur:
Spira, Alexander I. Iannotti, Nicholas O. Savin, Michael A. Neubauer, Marcus Gabrail, Nashat Y. Yanagihara, Ronald H. Zang, Edith A. Cole, Patricia E. Shuster, Dale Das, Asha